As of 2025-12-21, the Relative Valuation of Emergent BioSolutions Inc (EBS) is 19.37 USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.42 USD, the upside of Emergent BioSolutions Inc based on Relative Valuation is 55.9%.
The range of the Relative Valuation is 17.40 - 23.15 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 16.0x | 13.8x |
| Forward P/E multiples | 12.0x - 13.8x | 13.0x |
| Fair Price | 17.40 - 23.15 | 19.37 |
| Upside | 40.1% - 86.4% | 55.9% |
| Date | P/E |
| 2025-12-19 | 8.59 |
| 2025-12-18 | 8.51 |
| 2025-12-17 | 8.45 |
| 2025-12-16 | 8.44 |
| 2025-12-15 | 8.53 |
| 2025-12-12 | 7.90 |
| 2025-12-11 | 8.11 |
| 2025-12-10 | 8.00 |
| 2025-12-09 | 8.04 |
| 2025-12-08 | 8.21 |
| 2025-12-05 | 8.23 |
| 2025-12-04 | 8.34 |
| 2025-12-03 | 8.03 |
| 2025-12-02 | 7.51 |
| 2025-12-01 | 7.47 |
| 2025-11-28 | 7.73 |
| 2025-11-26 | 7.65 |
| 2025-11-25 | 7.58 |
| 2025-11-24 | 7.48 |
| 2025-11-21 | 6.95 |
| 2025-11-20 | 6.28 |
| 2025-11-19 | 6.84 |
| 2025-11-18 | 7.00 |
| 2025-11-17 | 6.99 |
| 2025-11-14 | 7.00 |
| 2025-11-13 | 7.14 |
| 2025-11-12 | 7.48 |
| 2025-11-11 | 7.53 |
| 2025-11-10 | 7.60 |
| 2025-11-07 | 7.03 |
| 2025-11-06 | 7.11 |
| 2025-11-05 | 7.15 |
| 2025-11-04 | 6.98 |
| 2025-11-03 | 7.26 |
| 2025-10-31 | 8.64 |
| 2025-10-30 | 8.88 |
| 2025-10-29 | 6.50 |
| 2025-10-28 | 6.55 |
| 2025-10-27 | 6.71 |
| 2025-10-24 | 6.74 |
| 2025-10-23 | 6.68 |
| 2025-10-22 | 6.53 |
| 2025-10-21 | 6.54 |
| 2025-10-20 | 6.80 |
| 2025-10-17 | 6.34 |
| 2025-10-16 | 6.50 |
| 2025-10-15 | 6.64 |
| 2025-10-14 | 6.29 |
| 2025-10-13 | 6.44 |
| 2025-10-10 | 6.28 |